PHAT
PHATHOM PHARMA (PHAT)
NASDAQ
$6.93-$0.15 (-2.12%)
Price as of Oct 02, 2026 4:15 PM EDT
  • $572.8M
    Market Cap
  • -40.10%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 51
Valuation
PHAT
vs History
vs S&P 500
Profitability
-0
Growth
1
Low Earnings Volatility
2

Momentum Score

Score: 14
Valuation
PHAT
vs History
vs S&P 500
3-Month Momentum
-13.46%
12-Month Momentum
-23.60%
3-Month Risk Adjusted Momentum
-39.75%
12-Month Risk Adjusted Momentum
-38.03%

True Yield

N/A
Valuation
PHAT
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
0.03%
Net Debt Paydown Yield
-0.10%

Financial Health Score

Score: 85
Valuation
PHAT
vs History
vs S&P 500
Ohlson's O-Score
5